Company
Medra
Medra is building the first [Physical AI Scientist](https://www.medra.ai) — a closed-loop system that tightly integrates AI scientific reasoning with…
- Founded
- 2022
- HQ
- San Francisco, California, USA
Funding
$52.0M
Models
1
Overview
Medra is building the first Physical AI Scientist — a closed-loop system that tightly integrates AI scientific reasoning with autonomous wet-lab experimentation. Founded in 2022, the San Francisco company operates ML001, a 38,000 sq ft autonomous lab where hundreds of off-the-shelf robots run continuous experiments across antibody discovery, protein engineering, gene editing, and cell biology. Partners including Genentech, Addition Therapeutics, Cultivarium, and DARPA access the platform through on-site deployments or remote operation.
Verified record
- Verified deployments
- None on file
- Active incidents
- None on file
DEPLOY Intelligence
Market intelligence for physical AI
Analyst-grade signals, competitive tracking, and investment context across the global physical AI landscape. Launching 2026.
Key facts
CEO
Michelle Lee, PhD
Total funding
$63M over 2 rounds
Flagship lab
ML001 — 38,000 sq ft autonomous lab, opened April 2026, built in 77 days
Head of Robotics
Aditya Agarwal (ex-Nimble)
Customers
Genentech, Addition Therapeutics, Cultivarium, DARPA
Financial stage
Early-stage (Series A, VC-funded)
Data & sources
Web sources
4
4 sources backing this record.View all →
Models (1)
View all models →Medra on the deployment map
Where Medra's robots are verified operating. Explore the deployment map by place and type.
Relationships
Current leadership (2)
- Michelle Lee CEO & Founder
- Aditya Agarwal Head of Robotics
Founders (1)
- Michelle Leeno longer at company
Safety record
No incidents on record for Medra.
Only active incidents are counted. Retracted incidents are excluded from this summary but remain reachable at their canonical URLs.
Full safety record: incidents, sourcing, and exposure data →
Recent coverage
Medra in third-party press
Partnerships (2)
- Medra x DARPA with DARPAdevelopment
- Medra x Genentech with Genentechdeployment
Funding rounds (2)
- Series A2025-12-11
$52M
Investors: Human Capital (lead), Lux Capital, Neo, NFDG, Catalio Capital Management, Menlo Ventures, 776, Fusion Fund
- Seed2025-09-12
$11M(reported)
Investors: Lux Capital (lead), Neo, NFDG
Sources (4)
- Medra Raises $52 Million Series A to Build Physical AI Scientists · https://www.roboticstomorrow.com/news/2025/12/11/medra-raises-52-million-series-a-to-build-physical-ai-scientists/25907
- https://www.medra.ai/series-a
- https://www.mobihealthnews.com/news/medra-raises-52m-partners-genentech
- https://www.hpcwire.com/off-the-wire/medra-launches-ai-experimentalist-and-announces-darpa-collaboration/
Common questions
- What is Medra?
- Medra is building the first Physical AI Scientist — a closed-loop system that tightly integrates AI scientific reasoning with autonomous wet-lab experimentation. Founded in 2022, the San Francisco company operates ML001, a 38,000 sq ft autonomous lab where hundreds of off-the-shelf robots run continuous experiments across antibody discovery, protein engineering, gene editing, and cell biology. Partners including Genentech, Addition Therapeutics, Cultivarium, and DARPA access the platform through on-site deployments or remote operation.
- What does Medra make?
- Medra has 1 robot model on the DEPLOY registry: ML001 (Medra builds both physical robots and the AI that runs them).
- Where is Medra headquartered?
- Medra is headquartered in San Francisco, California, USA.
- How much funding has Medra raised?
- Medra has raised approximately $52M in disclosed funding on record in the DEPLOY registry.
- Where does Medra operate robots?
- Medra is a robot manufacturer and does not directly operate deployments on the DEPLOY registry. Its products are deployed by customer operators; see the company page for the verified deployment record.
- When was Medra founded?
- Medra was founded in 2022.
- Is Medra safe?
- Medra has no incidents on record in the DEPLOY registry. This does not constitute a safety guarantee; it reflects the incidents DEPLOY has tracked and verified to date.
Methodology: Verified · 4 sources (no primary) · last reviewed 2026-07-14
Verification posture
Verified
Low confidence
Review state
Stable
Last reviewed 2026-07-14
Sources by quality tier
- 4
- unclassified
- Unclassified source
The framework is documented at /methodology. Corrections at /corrections. Reviewer: DEPLOY editorial team.
Methodology surface for Medra.In the press
Recent coverage mentioning Medra from third-party publications. Automatically surfaced; not part of the verified registry record.
Medra Launches AI Experimentalist and Announces DARPA Collaboration
Medra launched the AI Experimentalist, the scientific reasoning layer of its Physical AI Scientist Platform, and announced a DARPA-funded project using the system inside ML001,…
Medra Secures $52 Million Series A to Revolutionize Drug Discovery with Physical AI Scientists
Medra announced a $52M Series A led by Human Capital to build Physical AI Scientists that autonomously conduct experiments and interface with standard laboratory tools for drug…
Medra, a developer of AI-powered lab robots and scientists to advance drug discovery, raises $52M
Medra raised $52M in Series A to build the first physical AI scientist, integrating LLMs with robotic systems that run autonomous lab experiments for drug discovery.
Medra raises $52M, partners with Genentech
Medra secured $52M in Series A funding led by Human Capital and announced a partnership with Genentech to integrate its Physical AI and robotics into lab systems for drug…
Data Is a Robotics Problem, Medra CEO Says Physical AI Will Transform Biology
Medra CEO Michelle Lee explains how Physical AI that integrates scientific reasoning with wet-lab automation will accelerate biological discovery and drug development.
Machine-readable surfaces
- Markdown mirror: /companies/medra.md
- RSS feed: /companies/medra/feed.xml
- JSON-LD: embedded in this page’s head
- REST API: /v1/companies/9f55dd03-593e-434b-a5c3-d2a64829aace
- Revision history: /companies/medra/history
- Data documentation: /data
- Query this programmatically: Deploy MCP
Video
Unlock the future of drug discovery with AI-powered robots that could revolutionize science as we know it! Joining us at Catalio Conversations is Michelle Lee,
Medra, which programs robots with AI to conduct and improve biological experiments, has raised $52 million to build what it says will be one of the largest auto
At this Thursday Nights in AI, hosts Ali Rohde and Josh Albrecht discussed the future of robotics and computer vision, and the role of AI in the space. Special
AI-powered autonomous biology labs Founder: Michelle Lee Founder's LinkedIn: https://www.linkedin.com/in/amichlee/ Open roles: Full-Stack Engineer, Frontend
Medra builds systems to collect life science data with a level of precision and scale humans alone could never achieve. The company is led by Michelle Lee, PhD
In this presentation, Medra CEO Michelle Lee talked about why she's excited about robots and the key components of AI-enabled general-purpose automation (It's N
Introducing Medra, Physical AI in the Lab https://www.businesswire.com/news/home/20251211748411/en/Medra-Raises-%2452-Million-Series-A-to-Build-Physical-AI-Scie
"We are building the data engine that we believe is necessary to make science autonomous. Instead of opening a lab, we thought to ourselves, why couldn't we ope
AI is leaving the screen and entering the physical world, and the stakes couldn't be higher. Forbes AI reporter Anna Tong brings together Josh DeFonzo (Co-found